Advanced search
Publication Cover
Clinical Ophthalmology Volume 8, 2014 - Issue
Submit an article Journal homepage
97
Views
4
CrossRef citations to date
0
Altmetric
Original Research

An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan® RC Early Analysis Review (CLEAR) trial

Andrew C Crichton1 Division of Ophthalmology, University of Calgary, Calgary, AB, CanadaCorrespondence[email protected]
,
Donald R Nixon2 Private practice, Barrie, ON, Canada
,
Susan Simonyi3 Medical Affairs, Allergan Inc., Markham, ON, Canada
,
Meetu Bhogal3 Medical Affairs, Allergan Inc., Markham, ON, Canada
,
Christopher S Sigouin4 CLINWest Research, Burlington, ON, Canada
,
Marino J Discepola5 Department of Ophthalmology, McGill University, Montreal, QC, Canada
,
Cindy ML Hutnik6 Department of Ophthalmology and Pathology, Ivey Eye Institute, London, ON, Canada
,
Darryl C Baptiste3 Medical Affairs, Allergan Inc., Markham, ON, Canada
&
David B Yan7 Department of Ophthalmology, University of Toronto, Toronto, ON, Canada
 show all
Pages 1031-1038 | Published online: 23 May 2014

References

  • Canadian Ophthalmological Society Glaucoma Clinical Practice Guideline Expert CommitteeCanadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eyeCan J Ophthalmol200944Suppl 1S7S9319492005
  • ZimmermanTJHahnSRGelbLTanHKimEEThe impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistenceJ Ocul Pharmacol Ther20092514515219284321
  • KatzLJCohenJSBatoosinghALFelixCShuVSchiffmanRMTwelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertensionAm J Ophthalmol2010149661671. e120346780
  • AptelFCucheratMDenisPEfficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trialsJ Glaucoma20081766767319092464
  • NoeckerRSDirksMSChoplinNTBernsteinPBatoosinghALWhitcupSMA six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucomaAm J Ophthalmol2003135556312504698
  • GoldbergILiXYSelaruPPaggiarinoDA 5-year, randomized, open-label safety study of latanoprost and usual care in patients with open-angle glaucoma or ocular hypertensionEur J Ophthalmol20081840841618465724
  • LawSKSongBJFangECaprioliJFeasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance OrganizationOphthalmology20051122123213016225924
  • NixonDRSimonyiSBhogalMAn observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR TrialClin Ophthalmol201262097210323269858
  • ChenJDinhTWoodwardDFBimatoprost: mechanism of ocular surface hyperemia associated with topical therapyCardiovasc Drug Rev2005323124616252016
  • WoodwardDFKraussAHChenJThe pharmacology of bimatoprost (Lumigan)Surv Ophthalmol200145Suppl 4S337S34511434936
  • AstinMStjernschantzJSelénGRole of nitric oxide in PGF2α-induced ocular hyperemiaExp Eye Res1994594014087532135
  • KurtzSMannOIncidence of hyperemia associated with bimatoprost treatment in naïve subjects and in subjects previously treated with latanoprostEur J Ophthalmol20091940040319396785
  • AbelsonMBMrozMRosnerSAMulticenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertensionAdv Ther20032011312772813
  • CravenERLiuCCBatoosinghASchiffmanRMWhitcupSMA randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostClin Ophthalmol201041433144021188155
  • ParrishRKPalmbergPSheuWPXLT Study GroupA comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter studyAm J Ophthalmol200313568870312719078
  • PfennigsdorfSRamezOvon KistowskiGMulticenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertensionClin Ophthalmol2012673974622654501

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.